John P Schaumberg

Title: The Innovative Contributions of John P. Schaumberg

Introduction

John P. Schaumberg is a notable inventor based in Ypsilanti, MI (US), recognized for his significant contributions to the field of antibiotic compounds. With a total of 5 patents to his name, Schaumberg has made strides in developing antimicrobial agents that also exhibit antitumor properties.

Latest Patents

Schaumberg's latest patents include the CL-1957B antibiotic compound and its production. This invention details a purified isolate of an actinomycete identified as ATCC 39366, which is capable of producing the antimicrobial compound CL-1957B. The compound is produced by cultivating isolate ATCC 39366 under aerobic conditions in a culture medium containing assimilable sources of carbon and nitrogen until a substantial quantity of CL-1957B is generated. The patent also covers methods for isolating the compound and its pharmaceutical applications for treating microbial infections and tumors in mammals. Another significant patent is for the CL-1957A antibiotic compound, which follows a similar production process and also demonstrates antitumor properties.

Career Highlights

Schaumberg is associated with Warner-Lambert Company, where he has contributed to the development of innovative pharmaceutical solutions. His work has been pivotal in advancing the understanding and application of antibiotic compounds in medical treatments.

Collaborations

Throughout his career, Schaumberg has collaborated with notable colleagues, including Gerard C. Hokanson and James C. French. These collaborations have further enriched his research and development efforts in the pharmaceutical field.

Conclusion

John P. Schaumberg's innovative work in antibiotic compounds has made a significant impact on the medical community. His patents reflect a commitment to advancing healthcare through effective antimicrobial and antitumor solutions.